MUSTANG BIO INC (MBIO)
US62818Q2030 - Common Stock
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -23.42M | -51.60M | -77.53M | -66.37M | -60.02M | |||
| Depreciation Amortization | 900.00K | 1.86M | 2.72M | 2.17M | 1.68M | |||
| Change In Working Capital | 2.61M | -2.76M | 4.03M | -640.00K | 3.09M | |||
| Interest Paid | 12.00K | 1.35M | 2.71M | 0.00 | 1.59M | |||
| Other non cash items | 3.24M | 3.02M | 5.71M | 11.17M | 17.93M | |||
| OPERATING CASH FLOW | -16.67M | -49.48M | -65.07M | -53.67M | -37.32M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | -64.00K | -2.71M | -3.99M | -1.93M | |||
| Other Investing Activity | N/A | 5.95M | -240.00K | -1.38M | -2.49M | |||
| INVESTING CASH FLOW | -34.00K | 5.89M | -2.95M | -5.37M | -4.41M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | -30.38M | 30.00M | 0.00 | -15.75M | |||
| Stock Issued/Repurchased | 11.56M | 4.74M | 6.83M | 72.23M | 97.38M | |||
| Other Financing Activity | N/A | -445.00K | -2.77M | -1.38M | -3.51M | |||
| FINANCING CASH FLOW | 10.29M | -26.08M | 34.06M | 70.85M | 78.12M | |||
| CHANGE IN CASH | -6.42M | -69.67M | -33.96M | 11.81M | 36.39M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -16.67M | -49.48M | -65.07M | -53.67M | -37.32M | |||
| Capital Expenditure | N/A | -64.00K | -2.71M | -3.99M | -1.93M | |||
| FREE CASH FLOW | -16.70M | -49.54M | -67.78M | -57.66M | -39.25M | |||
All data in USD